1610 related articles for article (PubMed ID: 17974436)
21. Natural killer cell inhibition of young spherules and endospores of Coccidioides immitis.
Petkus AF; Baum LL
J Immunol; 1987 Nov; 139(9):3107-11. PubMed ID: 2444651
[TBL] [Abstract][Full Text] [Related]
22. Defective natural cytotoxicity in patients with cancer: normal number of effector cells but decreased recycling capacity in patients with advanced disease.
Steinhauer EH; Doyle AT; Reed J; Kadish AS
J Immunol; 1982 Nov; 129(5):2255-9. PubMed ID: 7119445
[TBL] [Abstract][Full Text] [Related]
23. Functional analysis of tumor-infiltrating leukocytes in breast cancer patients.
Wong PY; Staren ED; Tereshkova N; Braun DP
J Surg Res; 1998 Apr; 76(1):95-103. PubMed ID: 9695747
[TBL] [Abstract][Full Text] [Related]
24. Impaired in vitro interferon, blastogenic, and natural killer cell responses to viral stimulation in acquired immune deficiency syndrome.
Hersh EM; Gutterman JU; Spector S; Friedman H; Greenberg SB; Reuben JM; LaPushin R; Matza M; Mansell PW
Cancer Res; 1985 Jan; 45(1):406-10. PubMed ID: 2578099
[TBL] [Abstract][Full Text] [Related]
25. [Steroid receptors and NK cell activity in patients with breast cancer].
Konjević G; Branković-Magić M; Nikolić-Vukosavljević D; Spuzić I
Srp Arh Celok Lek; 1994; 122(5-6):139-42. PubMed ID: 17977410
[TBL] [Abstract][Full Text] [Related]
26. Interferon effect on cytotoxicity of peripheral blood and tumor-associated lymphocytes against human ovarian carcinoma cells.
Allavena P; Introna M; Sessa C; Mangioni C; Mantovani A
J Natl Cancer Inst; 1982 Apr; 68(4):555-62. PubMed ID: 6175786
[TBL] [Abstract][Full Text] [Related]
27. [Functional activity of the natural killers and macrophages in patients with breast tumors].
Andrianov IG; Voronov SM; Dobkin AN; Okulov VB; Orlov AB
Vopr Onkol; 1988; 34(12):1455-60. PubMed ID: 3265236
[TBL] [Abstract][Full Text] [Related]
28. Generation of suppressor cells for natural killer activity in cancer patients after surgery.
Uchida A; Kolb R; Micksche M
J Natl Cancer Inst; 1982 May; 68(5):735-41. PubMed ID: 6461792
[TBL] [Abstract][Full Text] [Related]
29. A mechanism by which human breast carcinoma cells escape the host immune system.
Hakim AA
Neoplasma; 1988; 35(6):691-705. PubMed ID: 3265486
[TBL] [Abstract][Full Text] [Related]
30. Decreased natural killer cytotoxic activity in chronic alcoholism is associated with alcohol liver disease but not active ethanol consumption.
Laso FJ; Madruga JI; Girón JA; López A; Ciudad J; San Miguel JF; Alvarez-Mon M; Orfao A
Hepatology; 1997 May; 25(5):1096-100. PubMed ID: 9141423
[TBL] [Abstract][Full Text] [Related]
31. Association of decreased NK cell activity and IFNγ expression with pSTAT dysregulation in breast cancer patients.
Konjevic G; Radenkovic S; Srdic T; Jurisic V; Stamatovic Lj; Milovic M
J BUON; 2011; 16(2):219-26. PubMed ID: 21766489
[TBL] [Abstract][Full Text] [Related]
32. Pretreatment of human peripheral blood lymphocytes with interleukin-2 or dexamethasone does not alter their response to Met-Enkephalin in a NK-cytotoxic assay.
Martin-Kleiner I; Gabrilovac J
Immunopharmacol Immunotoxicol; 1996 Feb; 18(1):37-57. PubMed ID: 8683038
[TBL] [Abstract][Full Text] [Related]
33. Natural killer and activated killer activities in chronic liver disease and hepatocellular carcinoma: evidence for a decreased lymphokine-induced activity of effector cells.
Hirofuji H; Kakumu S; Fuji A; Ohtani Y; Murase K; Tahara H
Clin Exp Immunol; 1987 May; 68(2):348-56. PubMed ID: 2820634
[TBL] [Abstract][Full Text] [Related]
34. Activated alpha 2-macroglobulin reverses the immunosuppressive activity in human breast cancer cell-conditioned medium by selectively neutralizing transforming growth factor-beta in the presence of interleukin-2.
Harthun NL; Weaver AM; Brinckerhoff LH; Deacon DH; Gonias SL; Slingluff CL
J Immunother; 1998 Mar; 21(2):85-94. PubMed ID: 9551359
[TBL] [Abstract][Full Text] [Related]
35. Effect of bitter melon (Momordica charantia Linn) on level and function of natural killer cells in cervical cancer patients with radiotherapy.
Pongnikorn S; Fongmoon D; Kasinrerk W; Limtrakul PN
J Med Assoc Thai; 2003 Jan; 86(1):61-8. PubMed ID: 12678140
[TBL] [Abstract][Full Text] [Related]
36. Estrogen receptor concentration and social factors as predictors of natural killer cell activity in early-stage breast cancer patients. Confirmation of a model.
Levy SM; Herberman RB; Lee J; Whiteside T; Kirkwood J; McFeeley S
Nat Immun Cell Growth Regul; 1990; 9(5):313-24. PubMed ID: 2077396
[TBL] [Abstract][Full Text] [Related]
37. [Accomplishments and perspectives in tumor diagnostics and treatment].
Spuzić I
Glas Srp Akad Nauka Med; 2002; (47):21-32. PubMed ID: 16078439
[TBL] [Abstract][Full Text] [Related]
38. Depletion of NK by cellular immunoadsorption.
Jensen PJ; Koren HS
J Immunol; 1979 Sep; 123(3):1127-32. PubMed ID: 89160
[TBL] [Abstract][Full Text] [Related]
39. Differential effects of recombinant human interferon-gamma and interleukin 2 on natural killer cell activity of peripheral blood in early human development.
Ueno Y; Miyawaki T; Seki H; Matsuda A; Taga K; Sato H; Taniguchi N
J Immunol; 1985 Jul; 135(1):180-4. PubMed ID: 3923100
[TBL] [Abstract][Full Text] [Related]
40. [The roles of soluble MICA in immune escape of breast tumor].
Ye YB; Zhou ZF; Chen Q; Li JY; Chen X; Huang WW
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Sep; 24(9):904-7. PubMed ID: 18782524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
